Luca Mazzarella
European Institute of Oncology(IT)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Retinoids in leukemia and cellular processes, Cancer, Lipids, and Metabolism, RNA modifications and cancer
Most-Cited Works
- → Tumor mutational burden quantification from targeted gene panels: major advancements and challenges(2019)315 cited
- → Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators(2010)310 cited
- → Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis(2019)306 cited
- → Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis(2017)220 cited
- → Wave Propagation in Sandwich Plates with Periodic Auxetic Core(2002)117 cited
- → Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program(2009)114 cited
- → The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review(2019)99 cited
- → p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value(2019)97 cited
- → Epigenetic Priming of a Pre-B Cell-Specific Enhancer through Binding of Sox2 and Foxd3 at the ESC Stage(2010)88 cited
- → Runx proteins regulate Foxp3 expression(2009)88 cited